NASDAQ:CASI

Casi Pharmaceuticals Stock Forecast

etoro logo Buy CASI
*Your capital is at risk
$1.19
-0.0700 (-5.56%)
At Close: Nov 17, 2025
AI Analysis AI Analysis of CASI
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Big movements in CASI Pharmaceuticals stock price on Monday moving 10.87% between high and low
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Oct 10, 2025 Loss -39.90%

The CASI Pharmaceuticals stock price fell by -5.56% on the last day (Monday, 17th Nov 2025) from $1.26 to $1.19. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 10.87% from a day low at $1.15 to a day high of $1.28. The price has fallen in 6 of the last 10 days and is down by -14.39% for this period. Volume has increased on the last day by 36 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 55 thousand shares were bought and sold for approximately $65.03 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -41.37% during the next 3 months and, with a 90% probability hold a price between $0.400 and $0.93 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

CASI Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The CASI Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.34 and $1.61. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, October 09, 2025, and so far it has fallen -41.95%. Further fall is indicated until a new bottom pivot has been found. CASI Pharmaceuticals gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for CASI Pharmaceuticals stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.125 between high and low, or 10.87%. For the last week, the stock has had daily average volatility of 8.99%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CASI) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect CASI Pharmaceuticals to open at $1.21, and during the day (based on 14 day Average True Range), to move between $1.12 and $1.26, which gives a possible trading interval of +/-$0.137 (+/-12.17%) up or down from last closing price. If CASI Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 12.17% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $1.31, some $0.120 (10.08%) from the current price of $1.19, our system finds the risk reward not very attractive.

Is CASI Pharmaceuticals stock A Buy?

CASI Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -7.674 Strong Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $1.21 ( 1.26%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

CASI Performance

Trading levels for CASI

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.33 11.76%
R2 1.28 7.75%
R1 1.25 5.27%
Price 1.19
S1 1.16 -2.75%
S2 1.13 -5.23%
S3 1.08 -9.24%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.42 19.33%
R2 1.36 14.29%
R1 1.31 10.08%
Price 1.19
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for CASI Pharmaceuticals Stock and on which exchange is it traded?
The symbol for CASI Pharmaceuticals is CASI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell CASI Pharmaceuticals Stock?
CASI Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy CASI Pharmaceuticals Stock?
CASI Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy CASI Pharmaceuticals Stock.

What's the current price of CASI Pharmaceuticals Stock?
As of the end of day on the Nov 17, 2025, the price of an CASI Pharmaceuticals (CASI) share was $1.19.

What is the 52-week high and low for CASI Pharmaceuticals Stock?
The 52-week high for CASI Pharmaceuticals Stock is $5.69 and the 52-week low is $1.09.

What is the market capitalization of CASI Pharmaceuticals Stock?
As of the Nov 17, 2025, the market capitalization of CASI Pharmaceuticals is 18.436M.

When is the next earnings date for CASI Pharmaceuticals?
The upcoming earnings date for CASI Pharmaceuticals is Mar 30, 2026.
Click to get the best stock tips daily for free!
ABOUT CASI PHARMACEUTICALS
CASI Pharmaceuticals
CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The company's product pipeline includes CNCT19, an autologous CD19 CAR-T inve...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE